ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Monthly Injectable BUP for MA Use Disorder (MURB) Trial

ClinicalTrials.gov ID: NCT05283304

Public ClinicalTrials.gov record NCT05283304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 11:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind, Placebo-controlled Trial of Monthly Injectable Buprenorphine (BUP) for Methamphetamine (MA) Use Disorder

Study identification

NCT ID
NCT05283304
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Madhukar H. Trivedi, MD
Other
Enrollment
18 participants

Conditions and interventions

Interventions

  • Buprenorphine injection (BUP-Inj) Drug
  • Placebo injection Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 23, 2023
Primary completion
Oct 19, 2023
Completion
Nov 18, 2023
Last update posted
Mar 20, 2025

2023

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
UCLA Vine Street Clinic Los Angeles California 90038
Highland Hospital, Alameda Health System Oakland California 94602
Oklahoma State University, Center for Health Sciences Tulsa Oklahoma 74107
CODA Portland Oregon 97214
UTSW Medical Center, Center for Depression Research and Clinical Care Dallas Texas 75247
University of Washington Medicine-Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05283304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2025 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05283304 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →